Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Julian Mitton MD Joins Zero Overdose as Medical Director, Pioneering Harm Reduction Nationwide

San Francisco's Dr. Julian Mitton Begins New Role

Zero Overdose, a leading national harm reduction nonprofit dedicated to expanding overdose safety planning and preventing unintentional overdose events and deaths, proudly announces the appointment of Julian Mitton, MD, MPH, as its new Medical Director. Dr. Mitton brings a wealth of experience and expertise to his role, further solidifying Zero Overdose's commitment to promoting evidence-based harm reduction strategies and fostering strategic partnerships across clinical providers, community-based organizations, nonprofits, and local governments.

In his capacity as Medical Director, Julian Mitton MD will serve as a clinical advisor, leader, trainer, and supporter, with a particular focus on research and evaluation. His diverse clinical background in population health and behavioral health, coupled with advanced training in health services research and implementation science, uniquely positions him to advance Zero Overdose's mission of saving lives and advocating for improved and equitable care for traditionally underserved populations.

"Joining Zero Overdose represents an incredible opportunity to make a tangible impact on the opioid crisis and other substance use challenges facing our communities," said Julian Mitton MD. "I am excited to collaborate with the dedicated team at Zero Overdose and leverage our collective expertise to expand overdose safety planning and drive meaningful change nationwide."

Founded in 2020 by Tom McCarry, LMHC, and Virna Little, PsyD, LCSW, Zero Overdose has rapidly grown into a pioneering force in the harm reduction space. The organization's Overdose Safety Plan©, developed in collaboration with healthcare providers and community stakeholders, has been instrumental in preventing unintentional overdoses and saving lives across multiple states. Zero Overdose's innovative approach has garnered widespread recognition and support, including partnerships with leading healthcare organizations and governmental agencies.

"Julian Mitton MD’s appointment marks an exciting new chapter for Zero Overdose as we continue to expand our reach and impact," said Tom McCarry, Co-founder and CEO of Zero Overdose. "His extensive experience and passion for public health will be invaluable as we work together to promote evidence-based harm reduction strategies and build healthier, more resilient communities."

Zero Overdose is committed to fostering a culture of collaboration and innovation in the fight against substance use disorders. Through strategic partnerships with Certified Community Behavioral Health Clinics (CCBHCs), Community-Based Health Organizations (CBHOs), and other stakeholders, the organization aims to amplify its impact and drive systemic change in healthcare delivery.

About Dr. Julian Mitton, MD, MPH:

Julian Mitton MD is a healthcare innovation leader and public health champion committed to advocating for the improved and equitable care of traditionally underserved populations. With a diverse clinical background in population health and behavioral health, and advanced training in health services research and implementation science, he has been able to leverage research, leadership, strategic partnerships, and health policy to advocate for underserved communities through clinical innovations and policy change. Julian Mitton MD's recent efforts have focused on tech-enabled population health and clinical innovations, including integrated behavioral health and programs to promote access to evidence-based medications for addiction treatment (MAT).

About Zero Overdose:

Zero Overdose is a national harm reduction nonprofit founded in 2020 with a mission to expand overdose safety planning and prevent unintentional overdose events and deaths. The organization's innovative approach leverages evidence-based strategies, strategic partnerships, and community engagement to promote safer, healthier communities. Zero Overdose is dedicated to advocating for improved and equitable care for traditionally underserved populations and driving systemic change in healthcare delivery.

Contact Info:
Name: Julian Mitton, MD
Email: Send Email
Organization: Julian Mitton, MD
Website: https://julianmittonmd.org/

Release ID: 89127013

If there are any deficiencies, problems, or concerns regarding the information presented in this press release that require attention or if you need assistance with a press release takedown, we encourage you to notify us without delay at error@releasecontact.com. Our diligent team is committed to promptly addressing your concerns within 8 hours and taking necessary actions to rectify any identified issues or facilitate the removal process. Providing accurate and trustworthy information is of utmost importance.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.